Blog
The 7 Types of C-Level in a Complex Purchase
In complex B2B sales, closing depends less on persuading and more on building internal consensus.
Gerardo Betancourt · Apr 1, 2026
Blog
403 articles on leadership, communication and professional development.
Blog
How to Create a Tribe with Inspirational Presentations
The inspirational presentation moves people to action from deep within: it doesn't persuade with data, but with a sense of belonging.
Gerardo Betancourt · Apr 1, 2026
Blog
How to Deliver a Presentation that Educates with Empathy
An effective educational presentation combines empathy, clarity and credibility, adapting the message to the audience to transform information into.
Gerardo Betancourt · Apr 1, 2026
Blog
How to Deliver a Promotional Presentation that Inspires
Effective promotional presentations: learn to differentiate empathy and assertiveness in sales
Gerardo Betancourt · Apr 1, 2026
Blog
How to Deliver an Executive Presentation with Impact and Leadership
Learn to design clear and assertive executive presentations, avoiding common mistakes and using them as leadership auditions to advance your career.
Gerardo Betancourt · Apr 1, 2026
Blog
The Trifecta of Effective Communication
Discover how to combine kindness, assertiveness, and empathy to communicate with impact, lead difficult conversations, and persuade without losing your essence.
Gerardo Betancourt · Apr 1, 2026
Blog
The 4 Types of Presentations According to Your Context
Present better in any context: discover how to combine empathetic and assertive communication in 4 types of presentations to plan your message and.
Gerardo Betancourt · Apr 1, 2026
Blog
Scientifically Proven Resources to Get Applause in Your Presentations
Discover what science says about applause in public presentations and how certain rhetorical devices can increase connection with your audience.
Gerardo Betancourt · Apr 1, 2026
Blog
The 2 Criteria Necessary for Education to Exist
Education is not having all the information or using AI, but persuading. Discover why no chatbot can replace what you do when teaching.
Gerardo Betancourt · Apr 1, 2026
Blog
What FDA Warning Letters Are and Why You Should Know About Them
Miraculous supplements? Be careful. The FDA publishes a list of companies selling illegal products. Check the Advisory Letters and avoid scams.
Tirso Najera · Apr 1, 2026
Blog
The Oncology Radar: Summary of Latest FDA Approvals (November-December 2025)
Summary of FDA oncology approvals (Nov-Dec 2025): Updates in amyloidosis, lymphoma and leukemia. Stay up to date with new treatments.
Tirso Najera · Apr 1, 2026
Blog
A New Cellular Opportunity: FDA Approves Breyanzi for Marginal Zone Lymphoma
FDA approves Breyanzi (CAR-T) for relapsed marginal zone lymphoma. 84% response rate. New hope for adult patients.
Tirso Najera · Apr 1, 2026
Blog
How Artificial Intelligence is Revolutionizing Drug Development
The FDA drives the use of Artificial Intelligence in drug development. Learn how CDER regulates this innovation to create safe medicines.
Tirso Najera · Apr 1, 2026
Blog
Breakthrough in Gastric Cancer: FDA Approves Durvalumab (Imfinzi) for Resectable Stages
FDA approves durvalumab (Imfinzi) + chemotherapy for resectable gastric cancer. Improves survival and complete response. Details here.
Tirso Najera · Apr 1, 2026
Blog
Hope Against Leukemia: FDA Grants Traditional Approval to Pirtobrutinib (Jaypirca)
FDA approves pirtobrutinib (Jaypirca) for CLL and SLL in adults. Learn about the benefits, safety, and BRUIN study data in this article.
Tirso Najera · Apr 1, 2026
Blog
Accelerated Approvals in Cancer: How They Work and Why They Matter
Accelerated approvals: early access to cancer therapies based on initial evidence while confirmatory studies are completed.
Tirso Najera · Apr 1, 2026
Blog
What is Drug Trials Snapshots
Drug Trials Snapshots summarize studies of new medications and show who participated, their results and effects helping to better understand each treatment
Tirso Najera · Apr 1, 2026
Blog
Lynozyfic, the new treatment everyone is talking about
Lynozyfic offers a new option for treating multiple myeloma, with good clinical results and risks that require medical monitoring.
Tirso Najera · Apr 1, 2026
Blog
New treatment approved for immunoglobulin A nephropathy
New treatment for immunoglobulin A nephropathy that reduces proteinuria and offers a promising option while its effects are being evaluated.
Tirso Najera · Apr 1, 2026
Blog
What's Happening with Ozempic?
The FDA issued an important alert: they found counterfeit units of Ozempic within the official drug supply chain in the United States.
Tirso Najera · Apr 1, 2026